The present invention relates to novel metalloproteinase inhibitors having an aryloxybenzenesulfonamide moiety and a carbamoylphosphonic acid moiety, to pharmaceutical compositions comprising them, and to their uses in the prevention and/or treatment of disease or disorder associated with MMP.
本发明涉及具有芳氧基苯磺酰胺基团和
氨基甲酰磷酸基团的新型
金属蛋白酶抑制剂,涉及包含它们的制药组合物,以及它们在预防和/或治疗与MMP相关的疾病或疾病中的应用。